Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70)

Ask supplier a question | View on supplier's website

Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) is a humanized monoclonal antibody that specifically recognizes and binds to CD70 molecular. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells and shows inhibitory efficacy against Burkitt’s lymphoma. MW : 150 kDa.

Supplier	Selleck Chemicals
Product #	A2312
Sku #	A2312-1mg*5
Pricing	1mg*5, $970.00

Feedback